Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein
Johannes P. M. Langedijk(Janssen (Netherlands)), Mark J. G. Bakkers(Corbion (Netherlands)), Richard Voorzaat(Janssen (Netherlands)), Roland Zahn(Johnson & Johnson (Israel)), Nicole V. Johnson(The University of Texas at Austin), Freek Cox(BMT Group (Netherlands)), Jarek Juraszek(Janssen (Belgium)), Leslie van der Fits(Erasmus MC), Lam Le(Janssen (Netherlands)), Jason S. McLellan(The University of Texas at Austin), Daan van Overveld(Janssen (Netherlands)), Ward van den Hoogen(Janssen (Netherlands))
Cited by 15
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k